Search Ontology:
ChEBI
riociguat
- Term ID
- CHEBI:76018
- Synonyms
-
- Adempas
- BAY 63-2521
- Methyl N-(4,6-diamino-2-{1-((2-fluorophenyl)methyl)-1H-pyrazolo(3,4-b)pyridin-3-yl}pyrimidin-5-yl)-N-methylcarbamate
- methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate
- riociguat
- riociguatum
- Definition
- A carbamate ester that is the methyl ester of {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamic acid. It is used for treatment of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension
- References
-
- CAS:625115-55-1
- Drug_Central:4807
- KEGG:D09572
- PMCID:PMC3363218
- PMID:19129292
- PMID:20424448
- PMID:20801938
- PMID:20956169
- PMID:21391889
- PMID:21789188
- PMID:22719060
- PMID:22900035
- PMID:22912874
- PMID:22936711
- PMID:23204120
- PMID:23397304
- PMID:23775260
- PMID:23883377
- PMID:23883378
- PMID:23883383
- PMID:23939482
- PMID:23963798
- PMID:23978639
- PMID:23997048
- PMID:23997053
- PMID:24015306
- PMID:24092345
- Patent:US2009286781
- Patent:WO2007009607
- Patent:WO2011147810
- Reaxys:12581953
- Wikipedia:Riociguat
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
Phenotype
Phenotype resulting from riociguat
Phenotype where environments contain riociguat
Phenotype modified by environments containing riociguat
Human Disease Model